Latest Governance News

Woodside Energy Group Ltd reported record production and a net profit after tax of $2.7 billion in 2025, advancing key LNG and ammonia projects while achieving its 15% emissions reduction target.

SKS Technologies Group has reported a robust half-year performance, driven by a landmark $130 million data centre contract and a strategic acquisition, positioning it strongly for FY26 growth.

Abacus Group has reported a strong turnaround with a $47.6 million net profit for the half-year to December 2025, maintaining steady funds from operations and declaring a consistent interim distribution. The group is also exploring internalising management of its key joint venture, Abacus Storage King.

Pacific Current Group reported a net loss for the half-year ending December 2025, driven by significant non-cash impairments and disposals, while repaying its senior secured debt and declaring a fully franked interim dividend.

Integral Diagnostics Limited has reported a robust half-year performance, with revenues soaring 55.6% and EBITDA nearly doubling, driven by strong patient volume growth and successful integration of Capitol Health. The company also declared a fully franked interim dividend of 3.3 cents per share.

Etherstack plc reported a robust FY2025 financial rebound with revenue soaring 70% to US$10.1 million, driven by major US project deliveries and a 62% rise in recurring support revenues. The company also turned EBITDA positive and secured key long-term contracts, setting the stage for strong growth in 2026.

MAAS Group Holdings has delivered a record half-year underlying EBITDA of $115.3 million, driven by strong growth in construction and real estate segments. The company also announced a major $1.7 billion divestment of its Construction Materials portfolio and a strategic $100 million investment in digital infrastructure.

Emerald Resources NL reported a 23% rise in half-year profit to $73.1 million, underpinned by solid gold production at its Okvau Gold Mine and significant progress across its Cambodian and Australian projects.

NZME Limited has reported a significant turnaround in 2025, posting a statutory net profit after tax of NZD 13.1 million and a 15% increase in operating EBITDA, underpinned by strong digital revenue growth across its divisions.

PYC Therapeutics reported a narrowed half-year loss of $22.8 million while progressing four RNA drug candidates through clinical stages. The company announced a major $653 million capital raising to extend its cash runway to 2030 and support ongoing development.

Sequoia Financial Group reported a 75.9% jump in operating profit for 1H FY26 despite a net loss after non-operating charges, prompting a cautious dividend cut amid regulatory challenges.

Apiam Animal Health has officially become a wholly owned subsidiary of Adamantem Capital's entities following a scheme of arrangement, with shareholders receiving a special dividend and a mix of cash and shares. The company will soon be delisted from the ASX.